Neuren Pharmaceuticals Limited (AU:NEU) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuren Pharmaceuticals Limited has announced a daily update on its ongoing on-market buy-back program, revealing that 37,029 ordinary shares were repurchased on the previous day, contributing to a total of 561,507 shares bought back to date. This strategic move is aimed at enhancing shareholder value by reducing the number of outstanding shares. Investors interested in Neuren’s financial activities may find this development noteworthy.
For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.